Publications by authors named "Harvey Reiser"

Claim this Profile
C
Comparison of visual function and patient-reported outcomes between two full range of field intraocular lenses: a randomized controlled study.
Satish S Modi, Robert P Lehmann, Bret L Fisher, Richard E Roth, Harvey Reiser

J Cataract Refract Surg· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
0
0.2% Betamethasone Sodium Phosphate: A Multicenter, Randomized, Double-Masked Study to Compare Its Ocular Safety, Tolerability, and Efficacy to Vehicle in Cataract Surgery Subjects.
Kamran Hosseini, Subba Gollamudi, Harvey Reiser, Tom Walters, Richard L Lindstrom

Clin Ophthalmol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcomes in a U.S. registration study of a new EDOF intraocular lens with a nondiffractive design.
Cathleen McCabe, John Berdahl, Harvey Reiser, T Hunter Newsom, Lisa Cibik

J Cataract Refract Surg· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The REVIVE Study: Long Term Outcomes of a Novel Non-Diffractive Extended Vision IOL versus Monofocal Control IOL.
Brian M Shafer, Cathleen McCabe, Harvey Reiser, T Hunter Newsom, John Berdahl

Clin Ophthalmol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective randomised clinical trial to evaluate the safety and efficacy of nepafenac 0.1% treatment for the prevention of macular oedema associated with cataract surgery in patients with diabetic retinopathy.
Ayala Pollack, Giovanni Staurenghi, Dana Sager, Bickol Mukesh, Harvey Reiser

Br J Ophthalmol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily nepafenac ophthalmic suspension 0.3% to prevent and treat ocular inflammation and pain after cataract surgery: phase 3 study.
Satish S Modi, Robert P Lehmann, Thomas R Walters, Raymond Fong, William C Christie, Harvey Reiser

J Cataract Refract Surg· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy.
Rishi Singh, Louis Alpern, Glenn J Jaffe, Robert P Lehmann, John Lim, Harvey J Reiser

Clin Ophthalmol· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nepafenac dosing frequency for ocular pain and inflammation associated with cataract surgery.
W Andrew Maxwell, Harvey J Reiser, Robert H Stewart, H Dwight Cavanagh, Thomas R Walters

J Ocul Pharmacol Ther· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis